Toth Financial Advisory
AIDX icon

Toth Financial Advisory’s 20/20 Biolabs Inc AIDX Stock Holding History

Toth Financial Advisory’s Portfolio AIDX Stock Details AIDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-100
Closed -$55 – 1122
2026
Q2 		$55 Sell
100
-57
-36% -$72 ﹤0.01% 873
2026
Q1 		$296 Buy
+157
New +$663 ﹤0.01% 861

Other funds holding AIDX

SignatureFD
SignatureFD Atlanta, Georgia $7.76B AUM 16.09% 1-Year Est. Return

Toth Financial Advisory's AIDX Position: Q3 2026 in Review

Toth Financial Advisory sold out of 20/20 Biolabs Inc (AIDX) in Q3 2026, closing a stake of 100 shares — an estimated $55 sold.

Toth Financial Advisory first reported a position in AIDX in Q1 2026 and held it in 2 quarters. The position peaked at $296 in Q1 2026. 1 fund tracked by Wall St. Rank holds AIDX as of Q3 2026.

  • Toth Financial Advisory reported no remaining 20/20 Biolabs Inc position as of Q3 2026 after selling out during the quarter.
  • Toth Financial Advisory sold 100 20/20 Biolabs Inc shares in Q3 2026, an estimated $55.
  • Toth Financial Advisory first reported a position in 20/20 Biolabs Inc in Q1 2026 and held it in 2 quarters.
  • Toth Financial Advisory's 20/20 Biolabs Inc position peaked at $296 in Q1 2026.
  • 1 fund tracked by Wall St. Rank held 20/20 Biolabs Inc as of Q3 2026.

Based on Toth Financial Advisory's 13F filing for Q3 2026, filed 8 Oct 2026.